(R)-1-Cyclohexyl-3-(4-methoxy-benzenesulfonyl)-6-oxo-hexahydro-pyrimidine-4-carboxylic acid hydroxyamide

ID: ALA269019

PubChem CID: 44264036

Max Phase: Preclinical

Molecular Formula: C18H25N3O6S

Molecular Weight: 411.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)N2CN(C3CCCCC3)C(=O)C[C@@H]2C(=O)NO)cc1

Standard InChI:  InChI=1S/C18H25N3O6S/c1-27-14-7-9-15(10-8-14)28(25,26)21-12-20(13-5-3-2-4-6-13)17(22)11-16(21)18(23)19-24/h7-10,13,16,24H,2-6,11-12H2,1H3,(H,19,23)/t16-/m1/s1

Standard InChI Key:  RCXJWFMVFQBLSC-MRXNPFEDSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  1  0  0  0  0  0999 V2000
    2.9417   -2.2625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -1.4375    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2375   -2.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542   -3.5042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542   -2.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -3.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2375   -3.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -2.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7417   -1.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -0.6375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417   -1.6500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3750   -3.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -4.7375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -1.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8042   -2.6792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3167   -1.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9417   -0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3167   -0.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7292   -0.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1125   -1.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0917   -2.2667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1167   -0.5667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -4.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7042   -1.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8000   -3.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0792   -5.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7917   -4.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  5  1  0
  5  1  1  0
  6  4  1  0
  7  3  1  0
  3  8  1  6
  9  2  1  0
 10  2  2  0
 11  2  2  0
 12  4  1  0
 13  6  2  0
 14  8  2  0
 15  8  1  0
 16  9  2  0
 17  9  1  0
 18 19  1  0
 19 17  2  0
 20 16  1  0
 21 15  1  0
 22 18  1  0
 23 12  1  0
 24 12  1  0
 25 22  1  0
 26 24  1  0
 27 23  1  0
 28 26  1  0
  7  6  1  0
 20 18  2  0
 27 28  1  0
M  END

Associated Targets(Human)

MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP7 Tchem Matrix metalloproteinase 7 (1073 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mmp13 Matrix metalloproteinase 13 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.48Molecular Weight (Monoisotopic): 411.1464AlogP: 1.08#Rotatable Bonds: 5
Polar Surface Area: 116.25Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.71CX Basic pKa: CX LogP: 0.84CX LogD: 0.82
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -0.93

References

1. Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE..  (2001)  Heterocycle-based MMP inhibitors with P2' substituents.,  11  (8): [PMID:11327577] [10.1016/s0960-894x(01)00137-8]
2. Verma RP, Hansch C..  (2007)  Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,  15  (6): [PMID:17275314] [10.1016/j.bmc.2007.01.011]

Source